You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ICL670

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
Has Results
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Beta-thalassemia, Iron Overload Trial in Los Angeles, Oakland, Chicago (Deferasirox)

Completed
Has Results
  • Beta-thalassemia
  • Iron Overload
  • Los Angeles, California
  • +2 more
Jun 8, 2021

Hepatic Impairment Trial in Kiel (Deferasirox)

Completed
  • Hepatic Impairment
  • Kiel, Germany
    Novartis Investigative Site
Dec 6, 2020

ß-thalassemia, Transfusional Iron Overload Trial in Cagliari, Genova, Orbassano (Deferasirox)

Completed
  • β-thalassemia
  • Transfusional Iron Overload
  • Cagliari, CA, Italy
  • +2 more
Dec 6, 2020

High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

Completed
  • High Risk MDS or AML Patients
  • Exjade® (deferasirox, ICL670)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 7, 2020

Aplastic Anemia Trial in Moscow (ICL670, Chelation, No chelation)

Terminated
Has Results
  • Aplastic Anemia
  • ICL670
  • +2 more
  • Moscow, Russian Federation
    Novartis Investigative Site
Jul 8, 2019

Transfusion-dependent ß-thalassemia Patients, Cardiac Iron Overload Trial in Athens, Patras (Deferasirox, Deferoxamine (DFO))

Terminated
Has Results
  • Transfusion-dependent β-thalassemia Patients
  • Cardiac Iron Overload
  • Athens, GR, Greece
  • +3 more
Oct 21, 2019

Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndrome
  • Iron Overload
  • Birmingham, Alabama
  • +47 more
Jul 21, 2021

Transfusion-dependent Hemachromatosis, Thalassemia Major, Sickle Cell Disease Trial in Boston (Deferoxamine, Deferasirox, HIDA)

Completed
Has Results
  • Transfusion-dependent Hemachromatosis
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Jun 14, 2019

Transfusion-dependent Iron Overload Trial in Worldwide (Deferasirox)

Completed
  • Transfusion-dependent Iron Overload
  • Adelaide, Australia
  • +97 more
Feb 8, 2020

Non-transfusion Dependent Thalassemia Trial in Worldwide (deferasirox)

Completed
Has Results
  • Non-transfusion Dependent Thalassemia
  • Nanning, Guangxi, China
  • +10 more
Sep 19, 2019

MDS, Iron Overload Trial in Stanford, Detroit, Houston (Deferasirox)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Iron Overload
  • Stanford, California
  • +2 more
Jun 1, 2021

MDS Trial in Worldwide (Deferasirox, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Anaheim, California
  • +71 more
Oct 30, 2020

MDS Trial in Toronto (Deferasirox + Azacitidine, Azacitidine)

Terminated
  • Myelodysplastic Syndromes
  • Toronto, Ontario, Canada
    Odette Cancer Centre, Sunnybrook Health Sciences Centre
Apr 24, 2018

Systemic Lupus Erythematosus (SLE) Trial in Worldwide (BIIB059, BIIB059-matching )

Recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Mesa, Arizona
  • +280 more
Jul 20, 2022

Chronic Iron Overload Trial in Austria, Greece, Italy (Deferasirox)

Completed
Has Results
  • Chronic Iron Overload
  • Vienna, Austria
  • +13 more
Feb 18, 2020

MDS, Transfusion Dependent Iron Overload Trial in Berlin (ICL670/Deferasirox)

Completed
  • Myelodysplastic Syndromes
  • Transfusion Dependent Iron Overload
  • Berlin, Germany
    Novartis Investigative Site
May 30, 2017

Acute Coronary Syndrome Trial in Worldwide (Milvexian, Placebo)

Not yet recruiting
  • Acute Coronary Syndrome
  • Alexander City, Alabama
  • +862 more
Feb 23, 2023

Anemia, Sickle Cell Trial in United States (ICL670, deferoxamine)

Completed
  • Anemia, Sickle Cell
  • ICL670, deferoxamine
  • Mobile, Alabama
  • +33 more
Aug 18, 2017

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • Anniston, Alabama
  • +618 more
Jun 3, 2022

Transfusional Iron Overload Trial in Greece, Italy, United States (ICL670)

Completed
  • Transfusional Iron Overload
  • ICL670
  • Oakland, California
  • +17 more
Feb 21, 2017

Prevention of Stroke or Systemic Embolism, Atrial Fibrillation Trial in Worldwide (Asundexian (BAY2433334), Apixaban, Asundexian

Recruiting
  • Prevention of Stroke or Systemic Embolism
  • Atrial Fibrillation
  • Asundexian (BAY2433334)
  • +3 more
  • Dothan, Alabama
  • +1128 more
Jan 5, 2023

Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

Completed
Has Results
  • Heart Failure
  • La Mesa, California
  • +519 more
Apr 26, 2021

MDS, Beta-Thalassemia Trial in Hungary (deferasirox)

Completed
  • Myelodysplastic Syndromes
  • Beta-Thalassemia
  • Budapest, Hungary
  • +3 more
Feb 22, 2017

Chronic Iron Overload Due to Transfusion-dependant Anemias Trial in Worldwide (Deferasirox dispersible tablet, Defearisox

Completed
Has Results
  • Chronic Iron Overload Due to Transfusion-dependant Anemias
  • Deferasirox dispersible tablet
  • Defearisox film-coated tablet
  • Orange, California
  • +50 more
Jul 22, 2017